Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...
A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...
A young woman with breast cancer was experiencing such intense hot flashes from her triplet chemotherapy regimen, AC-T, that ...
Other causes of lung cancer are well known, like radon gas exposure, which happens to be fairly prevalent in Appalachia. It’s ...
Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...
Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...
The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...
Addition of the immunotherapy drug pembrolizumab to standard of care for patients ... "Some patients also receive chemotherapy, but the data are mixed on its effectiveness and it's also very toxic, so ...
The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...
Malgorzata Kopec - who believes doctors are 'evil' - told the woman to wash her body and drink hydrogen peroxide and ...
The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback